Marlene Debel is CRO & VP at METLIFE INC (MET). They have made 5 open-market trades across 1 company since 2021, most recently 2026-08-31.
CIK 0001770295
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MET | 150,350 | $15.5M |
| RJF | 8,820 | $1.5M |
| Total | $17.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MET | SELL | 2026-06-01 | 2026-06-03 | $81.59 | $1.7M | +6.8% | +10.3% | +15.0% |
| MET | SELL | 2024-12-13 | 2024-12-17 | $82.88 | $3.8M | +0.5% | +5.9% | +1.3% |
| MET | SELL | 2023-08-09 | 2023-08-11 | $63.18 | $1.2M | -2.8% | -0.2% | -6.6% |
| MET | SELL | 2022-08-19 | 2022-08-23 | $67.60 | $274K | -0.7% | -3.1% | +15.9% |
| MET | SELL | 2021-05-11 | 2021-05-12 | $64.58 | $710K | +3.5% | +1.5% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.